Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia.
Saved in:
| Title: | Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Hu, Guan-hua1 (AUTHOR), Zuo, Ying-xi2 (AUTHOR), Zhang, Xiao-hui2 (AUTHOR), Wang, Yu2 (AUTHOR), Xu, Lan-ping2 (AUTHOR), Xin-lin, Hou1 (AUTHOR) houxinlin66@163.com, Cheng, Yi-fei2 (AUTHOR) yifeicheng1999@vip.sina.cn, Xiao-jun, Huang2 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Mar2026, Vol. 67 Issue 4, p846-852. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2025.2611117 |
